Tripeptidyl peptidase I and its role in neurodegenerative and tumor diseases

2Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tripeptidyl peptidase I (TPPI) is a lysosomal enzyme widely distributed inmammals and humans. Its genetically determined deficiency causes the classicallate-infantile form of neuronal ceroid lipofuscinosis, a fatal hereditary neurodegenerativedisease associated with severe symptoms and early death, usually inthe second decade of life. Many studies also show that TPPI is differentiallyregulated under various pathological conditions such as malignancy, neurodegeneration, ischemia, and inflammation, pointing at possible enzyme involvementin the pathogeneses of these entities. This chapter focuses on the TPPIparticipation in neurodegenerative and neoplastic diseases.

Cite

CITATION STYLE

APA

Dimitrova, M. B., Atanasova, D. Y., & Lazarov, N. E. (2017). Tripeptidyl peptidase I and its role in neurodegenerative and tumor diseases. In Pathophysiological Aspects of Proteases (pp. 147–160). Springer Singapore. https://doi.org/10.1007/978-981-10-6141-7_6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free